Report Compares Outcomes of 3 Glaucoma Drainage Implants
A study shows the devices ability to lower IOP and their associations with the need for additional interventions.
All articles by Salma Mahmoud
Atropine Sulfate Can Slow Progression of Mild to Moderate Myopia
Efficacy and safety of 3 different doses of atropine sulfate (DE-127) ophthalmic solution at slowing myopia progression.
GRAIL Study Supports Modular, Shape-Changing IOL
A study shows the 1 year stability of a fluid-filled intraocular lens that changes power.
Switching to Ranibizumab Prefilled Syringes Significantly Improved DME metrics
Switch from aflibercept resulted in significant central retinal thickness reductions and visual acuity improvements.
Canaloplasty Technique Lowers IOP, With or Without Phaco
A study shows the effect of ab-interno canaloplasty with iTrack for patients with glaucoma.
Gene Therapy May Offer Option in Leber Hereditary Optic Neuropathy
A novel gene therapy approach may manage MT-ND4 Leber hereditary optic neuropathy.
Proactive Diabetic Eye Disease Management Superior to Delayed Treatment
Earlier treatment with aflibercept improved outcomes in diabetic macular edema.
Once-Daily Omidenepag Isopropyl Noninferior to Timolol
An AAO presentation shows the potential of a glaucoma medication that may require fewer drops than timolol.
Topical Glaucoma Medications May Damage Lids
Researchers noted elevated rates of lacrimal drainage obstruction and lid malposition among patients using glaucoma drops.
- Loading...
Loading...
Next post in AAO 2021
Loading... 
Loading...